Hi Anon,
To answer your questions:
1) Yes, but be sure to add or update QMS procedures to address: a) identifying and meeting IVDD requirements and related regulations, b) vigilance, c) procedures for drawing up IVDD technical documentation and communication responsibilities between you and your Authorized Rep (be sure to qualify the AR under your supplier quality system and put in place a quality agreement with the AR), d) how to handle significant design changes for your CE Marked devices, and e) EU labeling requirements.
2) IVDs meeting CLSI requirements typically comply with IVDD. It is up to you to review the list of EU IVDD harmonized standards and determine those you can use to demonstrate compliance. These are voluntary, but if, for example, you choose to use the harmonized standard for reagent stability you may find that your studies to date fall short of some of the requirements.
3) I agree with Richard that if you are looking to update your risk system, go for the ISO 14971:2019. However, do know that even the new standard does not fully meet IVDD requirements. The IVDD has more strict requirements that are outlined in EN ISO 14971:2012 Annex ZC. Your choices here are to review these Annex ZC requirements against ISO 14971:2019 to see if you can accommodate these in the updated system, or consider (since you are already updating the system) making your updated system comply with IVDR requirements for risk analysis (specifically IVDR Annex I points 1-8).
I hope this helps!
------------------------------
Christie Hughes MT(ASCP), MPH
Senior Consultant, Qserve Group
Austin, TX
United States
------------------------------
Original Message:
Sent: 29-Oct-2020 08:30
From: Anonymous Member
Subject: In Vitro Diagnostics CE Marking Under the IVDD
This message was posted by a user wishing to remain anonymous
Hi all,
My employer who resides in the US has recently decided that they would like to begin CE marking their IVDs which would be under the IVDD until May 2022; all of our products would be self-certified. I have a general knowledge of the IVDD, but have some questions which I would really appreciate answers to:
1) Our QMS is ISO 13485:2016/MDSAP certified, can we leverage this in any way as a means of complying with the essential requirements?
2) We established performance characteristics for many of our products using the CLSI guidelines (FDA recognized consensus standards), can these standards be used to demonstrate compliance with the essential requirements? If not, which standards can be used and where can I find them?
3) Our risk management process conforms with ISO 14971:2007, which I know is not recognized in the EU. Rather than implementing EN 14971:2012 I think it would be smarter to implement ISO 14971:2019, as this is recognized by the FDA and will be replacing 14971:2007. Is ISO 14971:2019 going to be recognized by EU?
Thank you very much.